SEEK yields 2000000.00% · PFE yields 6.20%● Live data
📍 SEEK pulled ahead of the other in Year 1
Combined, SEEK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEEK + PFE for your $10,000?
TheDirectory.com, Inc. operates as an online local search and directory company in the United States. The company owns and operates a network of online local business directories and city guides, which provide business listings, directory information, and user generated reviews to consumers, who are searching online for services from local businesses through its business search engine, TheDirectory.com. It also operates various vertically targeted directories, such as Podiatrist.net, Chiropractor.net, 123HomeRepair.com, and DentistAppointments.com; and a network of Hello branded city guides, such as HelloNewYorkCity.com, HelloChicago.com, HelloMiami.com, and other guides. In addition, the company provides a suite of online marketing and branding solutions comprising search engine marketing, display advertising, Web presence, and online media and social networking products, as well as designs, develops, and deploys custom-built search engine optimized business Websites. It primarily serves small-and medium-sized businesses, advertisers focused on the local market, agencies, and resellers. The company was formerly known as Elysium Internet, Inc. and changed its name to TheDirectory.com, Inc. in May 2011. The company is based in Tampa, Florida. TheDirectory.com, Inc. is a subsidiary of FTS Group, Inc.
Full SEEK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.